Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
61,824,515
-
Share change
-
+1,992,222
-
Total reported value
-
$6,561,677,298
-
Put/Call ratio
-
14%
-
Price per share
-
$106.12
-
Number of holders
-
497
-
Value change
-
+$172,218,482
-
Number of buys
-
241
-
Number of sells
-
277
Institutional Holders of Jazz Pharmaceuticals plc - SHS USD (JAZZ) as of Q2 2025
As of 30 Jun 2025,
Jazz Pharmaceuticals plc - SHS USD (JAZZ) was held by
497 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,824,515 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock, Inc., LSV ASSET MANAGEMENT, Capital World Investors, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, AMERIPRISE FINANCIAL INC, JPMORGAN CHASE & CO, EcoR1 Capital, LLC, and FULLER & THALER ASSET MANAGEMENT, INC..
This page lists
498
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.